Interim vaccine effectiveness against influenza virus among outpatients, France, October 2025 to January 2026. [PDF]
De Clercq A +17 more
europepmc +1 more source
Antigenic analysis of influenza A(H3N2) isolates.
openaire +1 more source
Antigenic Variation of Recent Influenza A(H3N2) Viruses
openaire +3 more sources
Silver Nitrate and Bioactive Glass Containing Chitosan Coatings: Comparison of Antimicrobial and Antiviral Properties. [PDF]
Hadzhieva Z +10 more
europepmc +1 more source
Evolution and Vaccine Strain Match of <i>HA</i> and <i>NA</i> Genes of Influenza A/H3N2 Subtype in Riyadh, Saudi Arabia, 2020-2023. [PDF]
Alkubaisi NA +6 more
europepmc +1 more source
Genetic characteristics of influenza A/H3N2 virus in Jiaxing, China (2019-2024). [PDF]
Song Y +10 more
europepmc +1 more source
Real-World Effectiveness of Seasonal Influenza Vaccines During the 2024-2025 Season: Subgroup Analyses by Virus Subtype, Time Since Vaccination, and Diagnostic Method. [PDF]
Choi YJ +15 more
europepmc +1 more source
Influenza Surveillance in the Central African Republic From 2015 to 2018 to Inform Vaccination and Treatment Strategies. [PDF]
Komoyo GF +9 more
europepmc +1 more source
Influenza vaccine effectiveness among adults aged ≥60 years in northeastern Zhejiang Province, China, 2021-2024. [PDF]
Yu Z +13 more
europepmc +1 more source

